Lataa...
Design, mechanism, delivery and therapeutics of canonical and Dicer-substrate siRNA
Upon the discovery of RNA interference (RNAi), canonical small interfering RNA (siRNA) has been recognized to trigger sequence-specific gene silencing. Despite the benefits of siRNAs as potential new drugs, there are obstacles still to be overcome, including off-target effects and immune stimulation...
Tallennettuna:
| Julkaisussa: | Asian J Pharm Sci |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Shenyang Pharmaceutical University
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7032099/ https://ncbi.nlm.nih.gov/pubmed/32104477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajps.2018.12.005 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|